To better understand current and emerging prospects and difficulties in supply chain operations, we asked field experts for an account of what to expect in 2026.

Cal Bewicke of Ethical Naturals highlights research examining both the immediate and long-term effects of AlphaWave® L-Theanine on stress, sleep quality, and cognitive performance.

AHPA, ANH-USA, CRN and NPA are working to support the natural products industry on pressing topics including censorship, age-restriction efforts, the future of hemp-derived products and homeopathy, and more.

AHPA, CRN, and NPA react to the introduction of the Dietary Supplement Listing Act of 2026, renewing a debate within the natural products industry over the role of a mandatory product listing and dietary supplement oversight.

FDA's letter on the DSHEA disclaimer follows advocacy efforts from the AHPA, CRN, NPA, and others.

Created as an internal tool at Asa Waldstein’s consulting firm, collaborations with other industry members will help broaden the reach of the innovative regulatory compliance tool.

Attendees at the Legal, Regulatory, and Compliance Forum on Dietary Supplements will receive a comprehensive guide to the latest developments impacting the natural products industry. 

Read valuable perspectives from leading industry experts representing CRN, CHPA, Organic & Natural Health, INFRA, SENPA, WIN, GOED, U.S. Hemp Roundtable, ITC + GPA, and MAHO. You'll find the updates, insights, and action steps you need to help support the wellbeing of your business, and the industry overall, in the year ahead.

Consumers in the United States spent an additional $533 million on herbal supplements in 2023 compared to sales in 2022, but the former darling of the consumers—hemp-based phytocannabinoids such as cannabidiol (CBD)—are suffering blow after blow.

As companies in the dietary supplement space seek to navigate the regulatory requirements around claims substantiation, understanding the terminology used is critical to ensuring the science meets the message.